NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
June 8, 2026 — TransCode Therapeutics announces first live R&D webcast on June 18, 2026, highlighting Phase 2a trial of TTX-MC138 in colorectal cancer. Learn about updates to its RNA therapy pipeline.
June 8, 2026 — Onco-Innovations enters LOI with Nanosoft Polymers to develop ONC010 PNKP inhibitor for solid tumours, appoints Dave Antony as VP of corporate finance to support growth strategy.
June 8, 2026 — Oncotelic Therapeutics showcases PDAOAI platform at Qdrant Vector Space Day, accelerating drug discovery with AI and vector search. Learn how OTLC reduces development time and cost.
June 8, 2026 — GeoVax's Gedeptin therapy enhances checkpoint inhibitor responses in resistant metastatic solid tumors, as published in JCI Insight. Learn how intratumoral GDEPT activates systemic anti-tumor immunity.
June 8, 2026 — NeuroOne Medical Technologies (NMTC) to present at Planet MicroCap Las Vegas 2026 Conference. CEO Dave Rosa to discuss OneRF® platform updates for brain and pain treatment. Learn more.
June 8, 2026 — Lifordi Immunotherapeutics presents Phase 1 data for LFD-200, a subcutaneous ADC for RA, showing safety and anti-inflammatory effects without cortisol suppression. Dosing in RA patients ongoing.
June 8, 2026 — Nefense launches Hyponasal, Hyponasal Junior, and Hypobaby HOCl nasal sprays for age-specific airway health. Drug-free, antimicrobial, and anti-inflammatory solutions for adults, kids, and infants.
June 8, 2026 — Nefense launches hypochlorous acid nasal spray line for adults, children, and infants. Hyponasal spray offers gentle biocleanse, antimicrobial action, and allergy relief. Learn more about age-specific respiratory hygiene.
June 6, 2026 — Smart polymeric nanoparticles respond to tumor microenvironment signals to deliver immunotherapy precisely, turning cold tumors hot and reducing toxicity. Learn about this breakthrough from Southwest Jiaotong University published in Cancer Biology & Medicine.
June 6, 2026 — Hubbard Dianetics Foundation of Ventura joins global outreach for Mental Health Awareness Month, offering free stress tests and Dianetics resources to address stress and anxiety in the community.
June 6, 2026 — Nashville Concierge Medicines announces new adult ADHD content. Dr. William Conway offers holistic treatment for adults with ADHD in Nashville. Learn about symptoms and personalized care.
June 6, 2026 — The PERS market is projected to grow from $6.2B in 2025 to $11.5B by 2035, driven by aging populations, AI-powered fall detection, and home healthcare trends. Mobile PERS leads with 54% share.
June 5, 2026 — Voyageur Pharmaceuticals closes non-brokered private placement raising $5M under LIFE Exemption. Funds to advance FDA licensing for barium contrast products and Frances Creek project development. Learn more about the offering and company's vertical integration strategy.
June 5, 2026 — Seacoast Braces Miller Orthodontics is the only practice in Dover and Exeter, NH offering the Dynaflex Norris Passive Self-Ligating Bracket System. Learn more about this comfortable braces option.
June 5, 2026 — Sydney Injury Doctors offers same-day Certificates of Capacity for WorkCover and CTP claims, with telehealth and in-person options. Streamline your injury claim with a nominated treating doctor in Sydney.
June 5, 2026 — HighTide Therapeutics presents new renoprotective data for HTD1801 at ERA 2026, showing improved renal function in T2DM patients and mechanistic insights in podocyte injury models.
June 5, 2026 — Colombia nonprofit Centro de Transformacion Integral launches community development initiative integrating mental health, education, and social impact programs for holistic community empowerment.
June 5, 2026 — myhealthnetwork.com.au opens a multi-discipline allied health workspace in Revesby, NSW, offering purpose-built medical coworking spaces for health professionals seeking professional clinical environments and community.
June 5, 2026 — Oncotelic Therapeutics (OTLC) combines nanomedicine, AI, and robotics to advance precision oncology and rare disease therapies. Learn about its Deciparticle platform and PDAOAI ecosystem.
June 5, 2026 — Oncotelic Therapeutics (OTLC) advances nanoparticle drug delivery tech in oncology. Discover how Sapu003 and Deciparticle platforms aim to improve cancer therapy. Read more.